Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Depreciation & Amortization (CF): 2018-2025

Historic Depreciation & Amortization (CF) for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to $4.0 million.

  • Organogenesis Holdings' Depreciation & Amortization (CF) rose 12.86% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year increase of 14.10%. This contributed to the annual value of $13.6 million for FY2024, which is 30.39% up from last year.
  • Per Organogenesis Holdings' latest filing, its Depreciation & Amortization (CF) stood at $4.0 million for Q3 2025, which was up 7.90% from $3.7 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Depreciation & Amortization (CF) registered a high of $4.0 million during Q3 2025, and its lowest value of $1.0 million during Q1 2021.
  • In the last 3 years, Organogenesis Holdings' Depreciation & Amortization (CF) had a median value of $3.4 million in 2024 and averaged $3.2 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Depreciation & Amortization (CF) dropped by 24.83% in 2022, and later spiked by 100.00% in 2023.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Depreciation & Amortization (CF) stood at $1.8 million in 2021, then dropped by 14.51% to $1.5 million in 2022, then soared by 96.96% to $3.0 million in 2023, then increased by 21.23% to $3.6 million in 2024, then rose by 12.86% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $3.7 million for Q2 2025, and $3.4 million during Q1 2025.